All physiological systems have complex interactions-both intrinsic and with external systems. Sepsis is an archetypal example of a self-regulating complex system, with multiple cascading non-linear interactions and feedbacks, acting in series and in parallel, to form a "scale-free" network. The process of sepsis may be modelled in terms of complexity theory as an iterative progression from a stable, homeostatic pathway or attractor to an unstable attractor of immunological dissonance and death. Given the convolutions of the septic attractor, complexity theory neatly explains why so many "magic bullet" therapies for sepsis have failed when given alone, since reductionist approaches which test individual treatments one at a time are highly unlikely to be effective in isolation. A new methodology of synchronously testing multiple therapies needs to be developed.
Non-linear dynamic systems
Although great strides in the last decade have helped to elucidate the pathways to septic shock and multi-organ failure, specific interventions to modify the septic cascade remain elusive. Complexity theory may help us understand why single immunomodulatory therapies have so far failed to make a significant impact on the treatment of septic shock. In this review we suggest that the terminology relating to complex systems methods naturally describes the processes and treatment of sepsis.
The post-renaissance "scientific method" uses linear, deterministic explanations to understand a bewildering array of natural phenomena. Newton's laws of motion proclaim that action and consequence have a direct and linear relationship. This mechanistic philosophy-that the whole is the sum of its individual parts-still influences modern scientific thinking. However, no physical or biological system is ever isolated or simple. All dynamic systems are subject to multiple inputs and internal and external feedback. Even very simple systems may display irregular and unpredictable output. The mathematical quantification of these observations forms the basis of chaos theory. Similarly, complexity theory describes systems whose behaviour arises from the interactions of numerous subsystems. A common characteristic of such systems is the presence of pattern and order that is maintained in spite of irregular and variable input of energy and matter. For this reason they are called "non-equilibrium" systems. The study of complexity may explain the innate ability of an apparently randomly-designed system to follow a path of selforganization and stability. These patterns of selfregulation are well recognised in physiological systems 1, 2 .
A bestiary of complex systems
If left undisturbed by outside influences, a system will tend to settle down, with time, to a certain pattern of behaviour. In dynamic systems' jargon, this pattern of behaviour is called the system's "attractor". If the system is then transiently disturbed by some small external force, it will return towards its attractor. The region around the attractor -over which the attractor exerts its influence -is called the "basin of attraction", and the edge called the "basin boundary". Often the strength and stability of the attractor is proportional to the size of its basin of attraction. In physical systems, the attractor can only take on a few fundamental patterns: (i); it can be a steady state, like a pendulum returning to a single point if left long enough (a fixed point attractor), (ii) it can oscillate (a periodic attractor), or (iii) it can exhibit irregular but constrained behaviour (a strange attractor). Although not mathematically rigorous, it is intuitively reasonable to consider an attractor in a biological system as "the tendency for the system to adopt a preferred pattern of activity over time"-a way of quantifying the principle of homeostasis. For example, if a small bolus of adrenaline is given to a patient, the heart rate and blood pressure will tend to return to previous levels (i.e., a homeostatic attractor) after the transient increase. For an organism to survive in a complex world, it needs a broad repertoire of responses to different environmental challenges. It can be argued that healthy homeostasis is implied by the presence of a strange attractor rather than a fixed point attractor.
Unstable Complex Systems
Sometimes, complex systems may be influenced by internal or external forces to such an extent that they no longer fall within the previous attractor's basin of attraction, and follow another attractor. It may be hypothesized that the progress of infection, to sepsis, to septic shock is an example. Typically a system shows some characteristic behaviours when it is close to moving out of, or "bifurcating", from the original basin of attraction. Anthropomorphically, the system is "undecided" about what it should do. This progression, or bifurcation, to "sicker" attractors may be characterized statistically by increasing disorganization, which may manifest as: distorted and weakened internal feedback loops (e.g., lack of cardiovascular feedback loops post-myocardial infarction associated with increased mortality) 3 ; uncoupling of oscillating biological modulators that normally regulate the homeostatic attractor 4 ; fewer redundant pathways within the system with a concomitant reduction in the degree of order/complexity of that system (e.g., sepsis-induced regularization of heart rate variation) 5, 6 ; smaller basins of attraction, or distorted basin boundaries which allow behaviours that may destabilise the system (e.g., the sepsis-induced propensity for atrial fibrillation).
Septic Attractor(s)
The immune system -like any other natural system-is constantly bombarded by external agents, is subject to internal variation, and responds by positive and negative feedback on itself to exclude infec-tion. There is no "central organizer" for the reticuloendothelial system-it has the innate ability to selfregulate. Bone and co-workers 7, 8 proposed the model of the systemic inflammatory response syndrome (SIRS). Initiated by a variety of inflammatory agents, SIRS is a common pathway which may lead to vasodilatation, shock, consumptive coagulopathy, multi-organ failure and death. It is plausible to speculate that the sequence of the SIRS and the balancing counter anti-inflammatory response syndrome (CARS) as a whole may be considered as a series of increasingly dysfunctional attractors, or alternative pathways away from a stable milieu interieur.
The stages in the immune cascade from localized infection to a full-blown systemic response may each be seen as an attractor. Clinically each stage usually manifests as period of clinical plateaux, which we can measure by the amount of clinical support required, e.g., fluid resuscitation progressing to inotropes, further progressing to several-systems support for multiple organ failure. Each stage mirrors imprecisely the preceding and subsequent phases, in the sense that similar cellular and cytokine reactions may occur at localized or whole body level. Seen through the perspective of complexity theory, the aim of most supportive ICU treatment would be to extend the size of the basin boundaries, and thus make it more difficult for the patient to "overflow" from a relatively stable, homeostatic attractor to another, more inherently unstable septic attractor.
Taking endotoxin-initiated sepsis as an example, the molecular structure has been well elucidated 9 , the mechanisms of interaction with the immune system promulgated, and we are gaining a clearer picture of at least some of the basic cellular mechanisms 10 . However, one glance at the plethora of haematological and endothelial pro-and anti-inflammatory mediators unleashed by endotoxin will suggest that we are only now beginning to understand how these parts interact, and to tease out the important players, and how they work individually and in concert.
Not all gram-negative infections with endotoxin release lead to the SIRS. The size of the initial endotoxic insult (i.e., "the initial conditions") does not necessarily predict the size or outcome of the ensuing reaction. This is another characteristic of a complex system. Currently, we are unable to use initial clinical, biochemical and genetic markers to reliably predict who will develop septic shock [11] [12] [13] . Our inability to predict critical bifurcations towards septic shock is the result of inadequate information about individual host and pathogen initial conditions (specified by 8 ) The localised inflammatory and counter-inflammatory response may be seen as a stable, balanced attractor and a fractal of the larger SIRS and CARS. If, however, there is sufficient imbalance between SIRS and CARS, the immunological response bifurcates to follow another unstable attractor that may lead to the destruction of the system i.e. death. The aim of sepsis management should therefore be to maintain sufficient equilibrium to remain within a stable "bowl of attraction", or to nudge the attractor of immunological dissonance back towards a more balanced attractor. genetic polymorphisms and subsequent phenotypic variation in both host and pathogen); and the fact that we don't quantitatively understand the "laws of complexity" governing the myriad of subsequent cellular and biochemical interactions. Although these are complicated by their very nature, work in other fields of complexity (e.g., meteorology) suggests that these laws can be mathematically or statistically modelled in an increasingly sophisticated and predictive way. Attempts at modelling complex physiological and pathological systems have been attempted 2, 14, 15 .
Implications for the "magic bullet" treatment of sepsis
Despite the enormous range of agents trialed so far 16, 17 , our disease-modifying modalities for septic shock remain limited largely to the removal of infection and basic physiological support. It is likely that early goal-directed resuscitation 18 , intensive insulin therapy 19 and corticosteroid replacement therapy 20 play a role in the treatment of sepsis. However, the effects of specific immunomodulatory "magic bullet" therapies have been, by and large, spectacularly and expensively unsuccessful [21] [22] [23] [24] [25] . The recent activated protein C trial is the first disease-modifying agent to show significant statistical, and yet still modest clinical benefit in septic patients 26 ; and there is still some doubt about the initial trial methodology 27 . Although potentially useful, clearly protein C is not a panacea as a single agent, with twenty-six percent of patients receiving that treatment still dying. Similarly, attacking other facets of the septic cascade, with single interventions has met with limited success 28, 29 .
Scale-free networks: targeting multiple hubs of the septic attractor
So what might complexity theory suggest about the prospect of a "magic bullet" for septic shock? Single agents to block a specific arm of the septic cascade are almost certain to be ineffective in isolation, as they are likely to be bypassed and overlapped by other elements in this highly complex sequence. Obviously, the aim of treatment is to shift the patient's physiology from a deteriorating/septic attractor to a healthy attractor. The primary aim of treatment should not be to correct some deficiency (the mechanistic approach), but rather to re-establish normal multiple, redundant, internal communications within the system. This approach implies the application of many different treatments acting independently and at different targets, rather than one magic bullet. The trick will be to discover which pivotal components should be targeted. Almost every physiological system -from the opening times of ion channels, to the fluctuations of heart rate -displays signals with a characteristic statistical pattern ("fractal", or "power-law" time series). This is the signature of so-called "scale free" networks 30 . The term "scale-free" implies a heterogeneous distribution of connections between different elements in a system, which are dominated by a few highly connected sites. Most participating elements (termed "nodes") have relatively few interactions with other parts of the system, whereas a minority ofnodes (dubbed "hubs") have many connections. An example of a hub would be the pivotal role of the nuclear-factor kappa B complex in the innate immune response cascade 31 . Scale-free networks show a distinctive pattern of response to external or internal attack. They are highly resistant to the effects of random interventions, but are much more sensitive to interventions that specifically target the hubs. Simultaneous attack on several hubs can destabilize the scale-free network. Thus to effectively abort the septic cascade (and subvert the system from the septic basin of attraction back to that of normal homeostasis), several "hubs" would therefore need to be targeted simultaneously. The medical community knows intuitively that a treatment success is the cumulative result of addressing several hubs simultaneously; sound infrastructure and staff relationships, appropriate level of aggressiveness in application of individual treatments, and allied therapies that target the patient as a whole (e.g., nutrition, hygiene, physiotherapy). Similarly, haematological oncology has clearly shown that combinations of chemotherapeutic agents that target several critical "hubs" of the cell cycle are far more efficacious than single agent therapy.
It is likely, therefore, that effective sepsis management will involve -in addition to sound and meticulous resuscitation and organ support -simultaneous restriction of the release of toxins, modulation of coagulation, control of microcirculatory function, limitation of intracellular and mitochodrial dysfunction, and modification of excessive or inadequate paracrine/cytokine secretion, rather than one single "magic bullet" intervention. The reductionist rationale of testing a single putative magic bullet at a time to abort rampant sepsis may be likened to stopping a raging river with a single rock.
The corollary is that the plethora of individual immunomodulatory therapies that have not shown benefit in controlled trials should not be discarded. Meaningful progress in sepsis management may well require the simultaneous use of many different 449 CHAOTIC SEPSIS AND THE MAGIC BULLET products from competing drug companies. At current prices, this would be expensive. However if cooperation was sought in well-designed, independent trials to test complementary therapies from competing sources, we may come yet closer to making a significant impact in aborting sepsis in its early stages. The strategic use of existing agents in combination to target specific hubs of the inflammatory cascade may be the key to subvert the septic attractor to once again follow the attractor of normal physiology.
